FSMEX Holdings — Select Medical Technology and Devices Portfolio
All 66 reported holdings of Select Medical Technology and Devices Portfolio (FSMEX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Danaher Corp. | 15.09% | $449.37M |
| Thermo Fisher Scientific, Inc. | 14.06% | $418.63M |
| Intuitive Surgical, Inc. | 7.45% | $221.87M |
| Boston Scientific Corp. | 5.11% | $152.18M |
| Edwards Lifesciences Corp. | 4.21% | $125.38M |
| Stryker Corp. | 4.18% | $124.48M |
| Abbott Laboratories | 3.85% | $114.70M |
| Waters Corp. | 3.27% | $97.43M |
| Agilent Technologies, Inc. | 3.21% | $95.70M |
| West Pharmaceutical Svcs, Inc. | 3.09% | $92.00M |
| Fidelity Revere Street Trust | 2.89% | $86.14M |
| Bio Techne Corp. | 2.85% | $84.76M |
| Repligen Corp. | 2.17% | $64.45M |
| 10x Genomics, Inc. | 1.96% | $58.46M |
| Guardant Health, Inc. | 1.86% | $55.51M |
| Irhythm Technologies, Inc. | 1.72% | $51.26M |
| Sartorius Stedim Biotech | 1.71% | $50.90M |
| Caris Life Sciences, Inc. | 1.68% | $50.16M |
| Natera, Inc. | 1.56% | $46.46M |
| Veracyte, Inc. | 1.56% | $46.34M |
| Medline, Inc. | 1.54% | $45.70M |
| Illumina, Inc. | 1.53% | $45.63M |
| Bruker Corp. | 1.50% | $44.76M |
| Align Technology, Inc. | 1.09% | $32.37M |
| Waystar Holding Corp. | 1.07% | $31.86M |
| Iqvia Holdings, Inc. | 1.06% | $31.70M |
| Lifestance Health Group, Inc. | 1.03% | $30.71M |
| Insulet Corp. | 1.01% | $30.15M |
| Heartflow, Inc. | 0.99% | $29.43M |
| Lantheus Holdings, Inc. | 0.93% | $27.80M |
| Kestra Medical Technologies, Inc. | 0.68% | $20.20M |
| Element Biosciences, Inc. | 0.56% | $16.77M |
| Twist Bioscience Corp. | 0.56% | $16.72M |
| Kardium Inc/us | 0.55% | $16.36M |
| Minimed Group, Inc. | 0.52% | $15.41M |
| Veeva Sys, Inc. | 0.50% | $14.82M |
| Kardium Inc/us | 0.50% | $14.75M |
| Fidelity Revere Street Trust | 0.48% | $14.27M |
| Shoulder Innovations, Inc. | 0.47% | $13.93M |
| 10x Genomics, Inc. | 0.37% | $11.12M |
| Revvity, Inc. | 0.28% | $8.36M |
| Ceribell, Inc. | 0.26% | $7.68M |
| Freenome, Inc. | 0.23% | $6.71M |
| BECTON DICKINSON and CO | 0.20% | $5.88M |
| Almar Biosciences, Inc. | 0.19% | $5.72M |
| Manus Bio, Inc. | 0.19% | $5.71M |
| Aledade, Inc. | 0.19% | $5.62M |
| Icu Medical, Inc. | 0.18% | $5.42M |
| Dna Script Sas | 0.15% | $4.34M |
| Freenome, Inc. | 0.13% | $3.92M |
| Galvanize Therapeutics | 0.10% | $2.86M |
| Galvanize Therapeutics | 0.09% | $2.73M |
| Asimov, Inc. | 0.08% | $2.43M |
| Aledade, Inc. | 0.06% | $1.88M |
| Dmed Biopharmaceutical Co. Ltd. | 0.06% | $1.86M |
| Galvanize Therapeutics | 0.03% | $1.04M |
| Saluda Medical, Inc. | 0.03% | $758.34K |
| Elevatebio, LLC | 0.01% | $395.05K |
| Prognomiq, Inc. | 0.00% | $75.70K |
| Conformal Medical, Inc. | 0.00% | $70.75K |
| Dna Script Sas | 0.00% | $50.20K |
| Conformal Medical, Inc. | 0.00% | $35.38K |
| Dna Script Sas | 0.00% | $13.09K |
| Dna Script Sas | 0.00% | $830 |
| Conformal Medical, Inc. | 0.00% | $35 |
| Saluda Medical, Inc. | 0.00% | $0 |
FSMEX overview: performance, fees, allocation and SEC filings